Status:
RECRUITING
Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease
Lead Sponsor:
University of British Columbia
Conditions:
Parkinson Disease
Cognitive Impairment
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Cognitive impairment is common in Parkinson's disease. A recent study demonstrated 40% of people with PD suffer from mild cognitive impairment and \> 80% of patients develop dementia after a disease d...
Detailed Description
Objective: The objective of the proposed research is to test the ability of theta stimulation of the STN to modulate cognitive processing in PD patients by directly targeting associative STN circuitry...
Eligibility Criteria
Inclusion
- Those with STN DBS devices
- Those with pre- and post-operative imaging
- Those that are at least 3 months post-operative
Exclusion
- Those unable to complete the cognitive task (due to language barriers or dementia)
- Those with significant DBS complications
Key Trial Info
Start Date :
December 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT06518824
Start Date
December 1 2024
End Date
October 1 2025
Last Update
November 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leslie and Gordan Diamond Health Care Centre
Vancouver, British Columbia, Canada, V5Z 1M9